International news

Irish Family had to sell home after HSE fails to reimburse funds for medicinal cannabis

A family who were refused reimbursement by the HSE for medical cannabis for their five-year-old daughter have been forced to sell their home

Revealed: talks underway for first legal cannabis farm in Scotland

An Australian company has held talks with a local authority about building the first legal cannabis farm in Scotland.

Germany’s medical cannabis market prioritises efficacy over unfettered access

Germany may be the largest and fastest-growing medical cannabis market in Europe, but signs are emerging from medical and regulatory circles that should serve as a warning to cannabis companies planning to commercialise medicines without conclusive clinical trials.

The Opportunity of CBD - Reforming the Law

ver the past year, dietary supplements and foods containing cannabidiol (CBD) have swept into retail establishments and onto the Internet, with estimated annual U.S. sales now exceeding $200 million and growing rapidly.

CBD product sales are booming. Now the US-FDA needs to weigh in

Hemp-derived CBD is quickly becoming a multibillion dollar business with mainstream appeal. Clarity is needed.

‘Cannabis Walk’ in Thailand ends with hope for better access

The walk, which began in Phichit last month, underlined in particular the legal impasse that is blocking use for medical purposes

FDA pushes CBD manufacturers for more evidence at hearing

Food and Drug Administration regulators grill manufacturers and advocates for evidence that CBD actually does anything beneficial

France to launch medical cannabis experiment in coming weeks

As a nearly unanimous French Senate gave medical cannabis the green light on May 28, France will start experimenting the use of medical cannabis for “about two years”, pending the approval of the health ministry

Medicinal cannabis use is now legal in South Africa

The legalisation of medicinal cannabis has been heralded as a new-found hope and burgeoning market opportunity for South Africans

The world of Tilray: licensing and certification enhances capacity to export medical cannabis

Tilray Portugal has received a standard manufacturing license and a Good Manufacturing Practices (GMP) certification, in accordance with the European Medicines Agency’s (EMA) standards, for its Biocant Park manufacturing facility in Cantanhede, Portugal.